Consensus Statements Issued for Photoprotection for Skin of All Color
Consensus statements regarding sunscreen use and the associated risks from sun exposure have been developed by a panel of experts.
Consensus statements regarding sunscreen use and the associated risks from sun exposure have been developed by a panel of experts.
A novel study assessed the efficacy, safety, and improvement in QoL index in patients with melasma treated with topical 5% tranexamic acid with 30% glycolic acid peel.
Insurance coverage for topical treatments for rosacea vs melasma are investigated.
Treatment outcomes and adverse events of oral tranexamic acid (TA) in patients with vitiligo and melasma were assessed.
The effects of a synbiotics supplement (TS6) on improving melasma were investigated.
The study’s goal was to compare the clinical efficacy, safety, tolerability, and improvement in QOL index of three peeling agents for patients with melasma.
Data surrounding the association of UV exposure and risk for cutaneous melanoma in patients with skin of color was assessed.
The pressing need to clarify risk factors and effective interventions for skin of color populations is underscored.
The efficacy and safety of single-agent chemical peels in patients with pigmented skin, was investigated via a systematic review and meta-analysis of the current literature.
The racial and ethnic distribution of common dermatologic disorders seen at a US tertiary care center are characterized.